Poland: MidEuropa-backed Diagnostyka readying IPO in Warsaw
News reports point to MidEuropa-backed Diagnostyka, the largest medical laboratory chain in Poland, has started premarketing of an all secondary IPO on Warsaw’s stock...
UK: Cycle Pharmaceuticals completes acquisition of Banner Life Sciences
UK-headquartered Cycle Pharmaceuticals, a developer of treatments for the rare disease patient community, has completed the acquisition of US-based specialty pharma Banner Life Sciences....
Europe: Montagu announces intention to create a world-leading medical devices supplier
Montagu, a European-based mid-market private equity firm focused on Healthcare, Financial Sector Services, Critical Data, Digital Infrastructure, and Education, has announced its intention to...
Germany: Cube Biotech completes acquisition of IBA Lifesciences
Archimed-backed Cube Biotech, a provider of solutions for protein purification, stabilization, and structural studies, has acquired IBA Lifesciences, a biotechnology company providing products and custom...
Sweden: ELCG expands into Swedish vaccination market
Inflexion portfolio company, Denmark-based European LifeCare Group (ELCG), Europe’s largest independent provider of travel clinics and vaccinations, has taken another step in its pan-European...
UK: GSK to acquire IDRx for up to US$1.15bn
UK-headquartered global biopharma company GSK has agreed to acquire 100% of the outstanding equity interests (including all options and other incentive equity) in IDRx,...
UK: Alliance Pharma agrees takeover by DBAY Advisors
Alliance Pharma, a UK-based pharmaceutical company specializing in consumer healthcare products and prescription medicines, has agreed terms on a proposed cash offer for all...
Lithuania: Mehiläinen acquires InMedica Group to become largest private healthcare provider in the Baltics
Mehiläinen, Finland’s largest social care and healthcare provider with a growing international presence, has signed an agreement to acquire InMedica Group, the largest private...
Germany: STADA readies Fibig as chair pending IPO
Cinven and Bain Capital, the owners of STADA a Germany-based pharmaceutical company manufacturing consumer healthcare products, generics, and specialty pharmaceuticals, are considering various options...
UK: Verdiva Bio launches with over US$410m in Series A Financing to advance next-generation...
Verdiva Bio has announced its launch as a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders. Verdiva launches...
Advertisement
